Views & Analysis Reducing the burden on medical signatories The ABPI Code of Practice has always included strict requirements for the certification of promotional and some non-promotional activities and materials.
News After FDA says no, Bayer bags EU nod for twice-yearly Eylea Bayer has been given a leg up in the competitive market for VEGF therapies used to treat eye diseases with a new EU approval for Eylea 8mg.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face